LB Pharmaceuticals Raises $285M in Nasdaq IPO, Biggest Biotech Listing of 2025
New York (Patrika English News): U.S.-based biotech firm LB Pharmaceuticals has ended the biotech IPO dry spell in 2025 with a strong debut, raising $285 million through its listing on the Nasdaq Global Market. The company, focused on developing treatments for schizophrenia, offered 19 million shares at $15 each, higher than its earlier plan of … Read more